X4 Pharmaceuticals, Inc.

XFOR·NasdaqCM·Healthcare
Compare
3.2400+0.0700 (+2.21%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close3.1700
Open3.3000
Day range3.11003.3600
52-week range2.43004.8300
Off day high−3.57%
Off 52-week high−32.92%
Volume536.56K
Avg. volume (3M)864.13K
Market cap321.24M
EPS (TTM)0.0200
Forward P/E-4.22
P/E ratio (TTM)162.00
Dividend yield—
Beta (5Y)0.47
Shares outstanding99.15M
Short interest7.57% of float
Earnings dateNov 5, 2026 (est.)
Analyst target11.6000
Profit margin0.00%

Against its peers

Compare in full ›
XFOR CCCC XNCR XBRANE.ST XBIT CHRS
Market cap 321.24M 383.84M 2.60B 266.84M 59.45M 131.36M
P/E (TTM) 162.0 — — — — —
Forward P/E -4.2 -3.4 -9.9 647.5 15.0 -1.3
Price/book 1.6 1.6 4.0 0.5 0.5 2.2
Dividend yield — — — — — —
1-year change −7.56% +35.44% +150.21% +33.87% −6.13% −42.95%
Today +2.21% −2.80% +14.33% −3.36% −2.01% +5.54%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All XFOR news ›
The Manila Times·Positive

4DMT to Participate in Upcoming Investor Conferences

The Manila Times EMERYVILLE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with…

Business Plus·Positive

Xtremepush CEO Tommy Kearns to appear on Business Plus Talks

Xtremepush chief executive Tommy Kearns will guest on the next episode of Business Plus Talks, in association with Nostra. Every episode of Business Plus Talks features a business leader or entrepreneur who discusses the pivotal moments of…

From the 4Search news index, newest first.

In the news

26mentions in 30 days
14with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 26 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance